Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II/III Clinical Trial of Intensity Modulated Radiation Therapy With Concurrent Cisplatin for Stage I-IVA Cervical Carcinoma

NCT01554397 is registered in ClinicalTrials.gov with University of California, San Diego as lead sponsor.

NCT NCT01554397
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01554397 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II/III Clinical Trial of Intensity Modulated Radiation Therapy With Concurrent Cisplatin for Stage I-IVA Cervical Carcinoma
Lead sponsor
University of California, San Diego
Phase
Phase 2/3
Overall status
Completed
Start date
October 13, 2011
Completion date
January 1, 2022
Enrollment
101 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

cervical cancer